Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.01 SGD | 0.00% | 0.00% | -23.08% |
Apr. 16 | Singapore Shares Fall on Middle East Tensions; Medi Lifestyle Down 8% | MT |
Apr. 16 | Tritech Proposes Auditors Change; Shares Plummet 9% | MT |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 35.41 | 41.77 | 12.28 | 16.4 | 27.4 | 25.99 |
Enterprise Value (EV) 1 | 61.69 | 72.12 | 23.51 | 23.91 | 24.38 | 32.81 |
P/E ratio | -3.28 x | -1.54 x | -1.03 x | -3.54 x | -26.7 x | -2.12 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.55 x | 1.05 x | 1.15 x | 0.72 x | 1 x | 0.94 x |
EV / Revenue | 0.95 x | 1.82 x | 2.21 x | 1.05 x | 0.89 x | 1.19 x |
EV / EBITDA | -8.1 x | 1,069 x | -1.27 x | -6.66 x | 24.4 x | -7.18 x |
EV / FCF | 3.91 x | 14.5 x | 4.11 x | 11.7 x | 2.2 x | -3.84 x |
FCF Yield | 25.5% | 6.88% | 24.4% | 8.52% | 45.4% | -26% |
Price to Book | 0.65 x | 1.56 x | 0.75 x | 1.36 x | 2.38 x | 6.16 x |
Nbr of stocks (in thousands) | 907,971 | 907,971 | 944,868 | 964,868 | 1,014,868 | 1,181,534 |
Reference price 2 | 0.0390 | 0.0460 | 0.0130 | 0.0170 | 0.0270 | 0.0220 |
Announcement Date | 7/13/18 | 7/12/19 | 9/4/20 | 7/13/21 | 7/13/22 | 8/30/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 64.94 | 39.73 | 10.64 | 22.87 | 27.45 | 27.55 |
EBITDA 1 | -7.614 | 0.0675 | -18.47 | -3.588 | 0.9995 | -4.57 |
EBIT 1 | -12.28 | -4.291 | -20.17 | -4.594 | 0.032 | -5.52 |
Operating Margin | -18.91% | -10.8% | -189.52% | -20.09% | 0.12% | -20.04% |
Earnings before Tax (EBT) 1 | -21.06 | -8.737 | -21.97 | -4.666 | -0.7089 | -11.97 |
Net income 1 | -10.7 | -27.18 | -11.77 | -4.597 | -1.009 | -11.92 |
Net margin | -16.48% | -68.43% | -110.62% | -20.1% | -3.68% | -43.27% |
EPS 2 | -0.0119 | -0.0299 | -0.0126 | -0.004799 | -0.001011 | -0.0104 |
Free Cash Flow 1 | 15.76 | 4.961 | 5.727 | 2.038 | 11.07 | -8.534 |
FCF margin | 24.27% | 12.49% | 53.8% | 8.91% | 40.32% | -30.98% |
FCF Conversion (EBITDA) | - | 7,352.77% | - | - | 1,107.42% | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 7/13/18 | 7/12/19 | 9/4/20 | 7/13/21 | 7/13/22 | 8/30/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 26.3 | 30.4 | 11.2 | 7.51 | - | 6.82 |
Net Cash position 1 | - | - | - | - | 3.02 | - |
Leverage (Debt/EBITDA) | -3.451 x | 449.9 x | -0.6079 x | -2.092 x | - | -1.492 x |
Free Cash Flow 1 | 15.8 | 4.96 | 5.73 | 2.04 | 11.1 | -8.53 |
ROE (net income / shareholders' equity) | -33.1% | -20.9% | -100% | -32.4% | -8.64% | -150% |
ROA (Net income/ Total Assets) | -5.2% | -2.28% | -16.8% | -7.16% | 0.05% | -8.29% |
Assets 1 | 205.8 | 1,193 | 69.91 | 64.2 | -2,170 | 143.8 |
Book Value Per Share 2 | 0.0600 | 0.0300 | 0.0200 | 0.0100 | 0.0100 | 0 |
Cash Flow per Share 2 | 0.0100 | 0.0100 | 0 | 0 | 0.0100 | 0 |
Capex 1 | 0.65 | 1.98 | 0.33 | 0.57 | 0.34 | 1.21 |
Capex / Sales | 1% | 4.98% | 3.07% | 2.49% | 1.23% | 4.41% |
Announcement Date | 7/13/18 | 7/12/19 | 9/4/20 | 7/13/21 | 7/13/22 | 8/30/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-23.08% | 8.75M | |
+1.32% | 71.21B | |
-0.29% | 57.12B | |
+25.63% | 39.69B | |
+22.45% | 33.86B | |
+11.08% | 29.11B | |
+21.48% | 22.01B | |
+12.46% | 19.05B | |
+80.34% | 18.26B | |
+35.06% | 17.9B |
- Stock Market
- Equities
- 5G9 Stock
- Financials Tritech Group Limited